HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert O Williams Selected Research

Dosage Forms (Dosage Form)

12/2021In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters.
1/2021Novel formulations and drug delivery systems to administer biological solids.
8/2020The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation.
2/2008Advanced formulation design: improving drug therapies for the management of severe and chronic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert O Williams Research Topics

Disease

5Invasive Pulmonary Aspergillosis
01/2019 - 04/2006
3COVID-19
12/2021 - 08/2020
3Acute Lung Injury
01/2020 - 06/2018
3Lung Diseases (Lung Disease)
01/2020 - 05/2011
3Infections
08/2012 - 11/2008
2Dehydration (Water Stress)
10/2021 - 01/2021
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020 - 12/2019
2Idiopathic Pulmonary Fibrosis
01/2020 - 02/2018
2Fibrosis (Cirrhosis)
01/2020 - 12/2019
2Hemorrhage
01/2020 - 06/2018
2Lung Injury
12/2019 - 08/2018
2Neoplasms (Cancer)
05/2016 - 04/2014
2Pulmonary Edema
03/2010 - 09/2009
1Wounds and Injuries (Trauma)
10/2021
1Chronic Obstructive Pulmonary Disease (COPD)
10/2015
1Invasive Fungal Infections
08/2012
1Opportunistic Infections (Opportunistic Infection)
02/2011
1Aspergillosis
06/2009
1Mycoses (Diseases, Fungus)
11/2008
1Pain (Aches)
02/2008
1Chronic Pain
02/2008
1Inflammation (Inflammations)
06/2007

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
10/2021 - 02/2008
4PowdersIBA
12/2021 - 01/2019
4Dosage Forms (Dosage Form)IBA
12/2021 - 02/2008
3Excipients (Suspending Agents)IBA
08/2020 - 06/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2020 - 06/2018
3Peptides (Polypeptides)IBA
01/2020 - 02/2018
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2020 - 06/2018
3SmokeIBA
01/2020 - 06/2018
3Plasminogen Activators (Plasminogen Activator)IBA
01/2020 - 06/2018
3Voriconazole (Vfend)FDA LinkGeneric
01/2019 - 06/2009
3Itraconazole (Sporanox)FDA LinkGeneric
07/2007 - 04/2006
2SolutionsIBA
04/2014 - 04/2006
2AerosolsIBA
01/2014 - 03/2010
2Antifungal AgentsIBA
08/2012 - 11/2008
1remdesivirIBA
12/2021
1BuffersIBA
10/2021
1COVID-19 VaccinesIBA
04/2021
1VaccinesIBA
08/2020
1SuspensionsIBA
01/2020
1CaveolinsIBA
01/2020
1caveolin-1 (82-101)IBA
12/2019
1Amino AcidsFDA Link
12/2019
1indium-bleomycinIBA
12/2019
1Mannitol (Osmitrol)FDA LinkGeneric
01/2019
1TriazolesIBA
01/2019
1EnzymesIBA
08/2018
1FibrinIBA
06/2018
1AnticoagulantsIBA
06/2018
1Caveolin 1IBA
02/2018
1TabletsIBA
05/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2015
1Polysorbates (PSML)FDA Link
04/2014
1trimyristinIBA
04/2014
1Ethanol (Ethyl Alcohol)IBA
04/2014
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2014
1AzolesIBA
11/2008
1Analgesics (Analgesic Drugs)IBA
02/2008
1CytokinesIBA
06/2007

Therapy/Procedure

5Therapeutics
10/2021 - 02/2008
3Drug Therapy (Chemotherapy)
01/2019 - 02/2008
2Respiratory Therapy (Therapy, Respiratory)
10/2021 - 01/2014
1Dry Powder Inhalers
10/2021
1Lasers (Laser)
10/2021
1Lung Transplantation
02/2011